Clinical Characteristics and Adequate Treatment of Familial Adenomatous Polyposis Combined with Desmoid Tumors

被引:7
|
作者
Jung, Won Beom [1 ]
Kim, Chan Wook [1 ]
Kim, Jin Cheon [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg,Inst Innovat Canc Res, Seoul 138736, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2014年 / 46卷 / 04期
关键词
Familial adenomatous polyposis; Aggressive fibromatosis; Risk factors; AGGRESSIVE FIBROMATOSIS; MANAGEMENT; MORTALITY; IMATINIB; RISK;
D O I
10.4143/crt.2013.185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The objective of this study was to examine the clincopathologic characteristics and outcomes of familial adenomatous polyposis (FAP) patients with and without desmoid tumors (DTs), including the risk factors for progression of FAP-related DTs. Materials and Methods We reviewed the medical records and database of all patients with FAP who were treated between January 1993 and December 2011. Results Of 75 FAP patients, 18(24%) were FAP with DTs. Seventeen of these Had intra-abdominal DTs and one had intra- and extra-abdominal DTs. We divided the patients into two groups according to type of resection; the R0 or R1 resection group, referred to as the curative resection group (eight patients), and the R2 resection/palliative operation/medical treatment group, referred to as the palliative resection group (10 patients). Two patients In the curative resection group and two patients in the palliative group had progressed to tumor growth by the follow-up (p=0.800). In univariate analysis, DT diagnosis before or simultaneously with FAP diagnosis (DTs unrelated to surgical trauma) was a significant risk factor for tumor progression at final follow-up. Conclusion A multidisciplinary approach to DT treatment is needed, including nonsteroidal anti-inflammatory drugs, anti-estrogens, cytotoxic agents, and surgery. However, the role of surgery in resectable and complicated tumors may be limited. DT unrelated to surgical trauma has a relatively poor prognosis.
引用
收藏
页码:366 / 373
页数:8
相关论文
共 50 条
  • [21] Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis
    Nieuwenhuis, Marry H.
    Cappel, Wouter De Vos Tot Nederveen
    Botma, Akke
    Nagengast, Fokko M.
    Kleibeuker, Jan H.
    Mathus-Vliegen, Elisabeth M. H.
    Dekker, Evelien
    Dees, Jan
    Wijnen, Juul
    Vasen, Hans F. A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (02) : 215 - 219
  • [22] BREAST-CANCER, DESMOID TUMORS, AND FAMILIAL ADENOMATOUS POLYPOSIS
    FOULKES, W
    LANCET, 1993, 342 (8886-7): : 1560 - 1561
  • [23] Update on Familial Adenomatous Polyposis-Associated Desmoid Tumors
    Yang, Wanjun
    Ding, Pei-Rong
    CLINICS IN COLON AND RECTAL SURGERY, 2023, 36 (06) : 400 - 405
  • [24] MRI features of mesenteric desmoid tumors in familial adenomatous polyposis
    Azizi, L
    Balu, M
    Belkacem, A
    Lewin, M
    Tubiana, JM
    Arrivé, L
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 1128 - 1135
  • [25] Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis
    Campos, Fabio Guilherme
    Real Martinez, Carlos Augusto
    Novaes, Marleny
    Nahas, Sergio Carlos
    Cecconello, Ivan
    FAMILIAL CANCER, 2015, 14 (02) : 211 - 219
  • [26] Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis
    Fábio Guilherme Campos
    Carlos Augusto Real Martinez
    Marleny Novaes
    Sérgio Carlos Nahas
    Ivan Cecconello
    Familial Cancer, 2015, 14 : 211 - 219
  • [27] Desmoid disease in familial adenomatous polyposis
    Nugent, KP
    FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 171 - 175
  • [28] Doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis (FAP).
    Gega, M
    Yanagi, H
    Noda, M
    Yoshikawa, R
    Yamamura, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 273S - 273S
  • [29] Desmoid tumors in familial adenomatous polyposis: A pilot project evaluating efficacy of treatment with pirfenidone
    Lindor, NM
    Dozois, R
    Nelson, H
    Wolff, B
    King, J
    Boardman, L
    Wilson, M
    Greene, MH
    Karnes, W
    Mesa, R
    Welch, T
    Edmonson, J
    Limburg, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (08): : 1868 - 1874
  • [30] PHARMACOLOGICAL TREATMENT OF DESMOID TUMORS IN FAMILIAL ADENOMATOUS POLYPOSIS - RESULTS OF AN IN-VITRO STUDY
    TONELLI, F
    VALANZANO, R
    BRANDI, ML
    SURGERY, 1994, 115 (04) : 473 - 479